Compared with that in healthy tissue, the expression of HYAL2 was significantly decreased in endometrial cancer; in contrast, the expression in breast cancer was markedly increased, especially at the margins of invasive breast cancer [19–21]. Here, HYAL2 is linked to endometrial cancer.